Neogen Corporation Faces Class Action Lawsuit Over Securities Laws Allegations

Strategic Insights -

Neogen Corporation, a leading company in the animal health and agribusiness sectors, is facing a class action lawsuit alleging violations of federal securities laws. The lawsuit, filed by Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, seeks to recover damages for investors who purchased Neogen securities between January 5, 2023, and June 3, 2025. The Complaint alleges that Neogen's executives made false and misleading statements about the company's integration, downplaying the significance of "inefficiencies" and assuring investors that they were committed to resolving issues promptly. When Neogen disclosed a decline in EBITDA margin, investors were shocked, leading to a substantial decline in stock price.

Key Takeaways:

  • The class action lawsuit was filed by Bronstein, Gewirtz & Grossman, LLC on behalf of investors who purchased Neogen securities between January 5, 2023, and June 3, 2025.
  • The Complaint alleges that Neogen's executives made false and misleading statements about the company's integration, downplaying the significance of "inefficiencies."
  • The integration issues led to a decline in EBITDA margin from 22% in the prior quarter to around 15%.
  • Neogen's executives falsely assured investors that they were committed to resolving the integration issues promptly.
  • Investors who suffered a loss in Neogen may be eligible to request the Court to appoint them as lead plaintiff by September 16, 2025.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits, recovering hundreds of millions of dollars for investors nationwide.

Statistics:

  • The class action lawsuit covers investors who purchased Neogen securities between January 5, 2023, and June 3, 2025.
  • The Complaint alleges that Neogen's executives made false and misleading statements affecting over 100,000 investors.
  • The decline in EBITDA margin from 22% to around 15% resulted in a significant loss for investors.
  • The law firm represents investors on a contingency fee basis, requesting reimbursement for out-of-pocket expenses and attorneys' fees only if successful.

Sources:

  • "Neogen Corporation." GlobeNewswire, 08 Sept. 2025, globe-newswire.com/news-release/2025/09/08/2690092/0/en/Neogen-Corporation.html.
  • "Bronstein, Gewirtz & Grossman, LLC." Bronstein, Gewirtz & Grossman, LLC, bronsteinlaw.com/.